# The Medicines (Advertising) Amendment Regulations 1996, Regulation 2: Amendment of regulation 6 of and Schedule 1 to the principal Regulations


(1) For regulation 6 paragraph (2) of the principal Regulations (prohibition of advertisements referring to specified diseases), there shall be substituted the following paragraph—
“(2) Paragraph (1) shall not be taken to prohibit a person from issuing an advertisement which is likely to lead to the use of a relevant medicinal product—
(a) for the purpose of the prevention of neural tube defects; or
(b) for the purpose of the treatment of
(i) the symptoms of sprains or strains, or
(ii) the pain or stiffness of rheumatic or non-serious arthritic conditions.”.
(2) In Schedule 1 to the principal Regulations (diseases in respect of which advertisements to the public are prohibited), after the entry “Genetic disorders” there shall be inserted the entry “Joint, rheumatic and collagen diseases”.

---
Source: https://www.legislation.gov.uk/uksi/1996/1552/regulation/2 (the official version)
Page: https://openlegislation.uk/medicines-advertising-amendment-regulations-1996/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.